The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.10 - Manufacture of basic pharmaceutical products
243 jobs Number of planned job losses
Announcement Date
3 October 2013
Employment effect (start)
30 November 2013
Foreseen end date
Description
The Italian subsidiary Merck Sharp and Dohme (MSD) of world-wide operating pharmaceutical group Merck is to cut 243 jobs. It was announced that cuts will mostly affect sales representatives.
The trade unions reacted to the company’s decision by organizing worker protests.
Merck is based in Whitehouse Station (New Jersey, US) and employs over 80,000 staff worldwide. The main part of the Italian workforce (around 1,000 workers) is employed in a site located in Rome.
Eurofound (2013), Merck, Internal restructuring in Italy, factsheet number 76005, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/76005.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
